13F HOLDINGS REPORT
RiverVest Venture Management LLC
Quarter ended Q3 2024 · Filed October 30, 2024 · Accession 0001104659-24-112539
Total Value
$6.8M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Reneo Pharmaceuticals, Inc. | 75974E103 | 2,534,220 | $4.3M | 63.00% |
| 2 | Spruce Bioscience, Inc. | SPRB | 2,936,281 | $1.4M | 20.39% |
| 3 | Xilio Therapeutics, Inc. | XLO | 1,441,444 | $1.1M | 16.60% |